How Companies in Russia Can Source Pharma Products & CDMO Services (2026 Guide)
Russian Federation • Source Pharma Products & CDMO Services
Introduction
Russia is one of the largest pharmaceutical markets in Eurasia. Buyers include distributors, pharmacy chains, hospital networks, regional health authorities buying through public procurement, and local manufacturers that need APIs or contract capacity.
The market runs on Eurasian Economic Union (EAEU) rules. Medicines are registered under the common EAEU procedure, with the Ministry of Health (Minzdrav) as the Russian registration authority, the Federal Service for Surveillance in Healthcare (Roszdravnadzor) overseeing products on the market, and GMP inspections organised by the Ministry of Industry and Trade (Minpromtorg).
This guide explains where supply for Russia typically comes from, what buyers source, how to qualify suppliers, the documents involved and the practical problems to plan for. For more market background, see our Russia country hub.
Where supply comes from
Russian buyers use a mix of domestic and imported supply. Local production has grown, but many APIs, biologics and specialty products still come from abroad.
| Supply base | Typical strengths for Russian buyers |
|---|---|
| Domestic Russian manufacturing | Many generics and hospital products, often preferred in public procurement |
| Other EAEU states (Belarus, Kazakhstan, Armenia, Kyrgyzstan) | Generics registered under common EAEU rules, with shorter logistics |
| India and China | Generic APIs, intermediates and high-volume finished generics |
| Europe (EU-GMP) | Biologics, sterile injectables, complex generics and specialty medicines |
| Turkey, South Korea and other Asian sources | Branded generics, biosimilars and selected APIs |
As everywhere, judge the site and product, not the country. The key questions are whether the site holds or can obtain an EAEU or Russian GMP certificate, whether its dossier meets EAEU requirements, and whether it can supply Russian-language packaging with the required digital marking.
Pharma categories supply
| Category | What buyers typically source |
|---|---|
| APIs and intermediates | Antibiotics, cardiovascular, antidiabetic and GI molecules for local formulation |
| Finished generics | Tablets, capsules, syrups and sachets for retail and hospital channels |
| Hospital injectables | Antibiotics, anaesthetics, oncology injectables |
| Biologics and biosimilars | Insulins, monoclonal antibodies |
| OTC and consumer health | Analgesics, cold and flu products, vitamins |
| Dietary supplements | Vitamins and health supplements, which follow separate rules from medicines |
CDMO services in demand
- Technology transfer to Russian or EAEU manufacturing sites
- Contract manufacturing of finished generics and private-label products
- Formulation development and reformulation
- Stability studies under Zone II conditions
- Russian-language packaging with serialisation for digital marking
- Clinical and pilot batches
Localisation is a strong theme. Many foreign suppliers now license dossiers or transfer technology to local plants rather than ship finished products, especially for public procurement.
How to source pharma products
1. Define the requirement
Set out the molecule, strength, dosage form, pack size, annual volume, price basis and target channel. Check whether the product already has an EAEU registration and appears in the EAEU Unified Register.
2. Qualify the supplier
Ask for:
- A valid EAEU or Russian GMP certificate, or a clear plan and timeline for inspection
- The national GMP certificate and manufacturing authorisation from the site's own regulator
- A Certificate of Pharmaceutical Product (COPP)
- Certificates of Analysis for recent commercial batches
- Long-term stability data under Zone II conditions
- API DMF access and the latest audit report
Our guide on how to verify a pharmaceutical supplier explains how to check certificates and spot warning signs.
3. Plan registration and GMP
Confirm that the dossier is in CTD format and meets EAEU requirements, that Russian translations are ready, and who will act as marketing authorisation holder or its local representative. Build the GMP inspection into the timeline.
4. Check compliance before you commit
Buyers and suppliers must check the current sanctions and export-control rules in their own jurisdictions, and those that apply to their banks, insurers and carriers, before agreeing a transaction. The rules differ between countries and change over time, so confirm them with compliance or legal advisers.
5. Agree terms and run a pilot
Settle MOQ, lead time, Incoterms, currency, payment route and minimum shelf life, sign a quality agreement, then start with a smaller first order.
PharmaTradz works with GMP-certified manufacturers and CDMOs across Asia, Europe, the Americas and Africa. You can share your specification through a request for quotation.
Required documents for import
For registration
- CTD dossier meeting EAEU requirements, with Russian-language documents
- EAEU or Russian GMP certificate for each manufacturing site
- COPP or equivalent evidence of approval elsewhere, where relevant
- Zone II stability data
- Bioequivalence data for generics
- Russian-language label and patient leaflet text
- Samples and reference standards for expert testing
For each shipment
- Commercial invoice and packing list
- Batch Certificate of Analysis and the manufacturer's batch release documents
- Certificate of origin
- Bill of lading, air waybill or CMR road consignment note
- Customs declaration filed by the licensed importer
- Digital marking data for each pack
- Temperature records for cold-chain goods
Make sure batch numbers, quantities and product names match across every document and the marking data.
Logistics and shipping
Russia is large, so the entry point matters as much as the origin.
- Sea: St Petersburg on the Baltic, Novorossiysk on the Black Sea and Vladivostok on the Pacific coast.
- Air: Sheremetyevo, Domodedovo and Vnukovo airports in Moscow, and Pulkovo in St Petersburg.
- Rail and road: overland routes through Central Asia and the Caucasus, and road freight from other EAEU states.
| Origin | Air freight | Sea or multimodal |
|---|---|---|
| South and East Asia | Typically 3–7 days | Typically 4–8 weeks, depending on route |
| Europe | Typically 3–8 days, often with transit stops | Typically 2–6 weeks by road or sea |
Direct air links with some countries are limited, so routings can be longer than the distance suggests. Confirm options and lead times with your forwarder.
Cold chain
Winter cold is as much a risk as summer heat. Use GDP-compliant forwarders, validated packaging and data loggers, and protect liquids and biologics from freezing. Our cold-chain logistics service covers the options.
Incoterms and customs
FCA, CPT and DAP are common. Customs clearance takes place under EAEU customs rules, and products must be entered into the national digital marking system before sale.
Legal and regulatory overview
EAEU registration
Since 1 January 2026, medicines in EAEU states need registration under EAEU rules. Products registered nationally had to bring their dossiers into line with EAEU requirements to stay on the market. In Russia, Minzdrav handles registration and expert review.
Market surveillance
Roszdravnadzor oversees quality, safety monitoring and pharmacovigilance for products on the market, and it can order products withdrawn.
GMP inspection
Foreign sites usually need an EAEU or Russian GMP certificate, obtained through an inspection organised by Minpromtorg. The site's own GMP documents support the application but do not replace the inspection. Certificates are time-limited, so track renewals.
Labelling and marking
Labels and leaflets must be in Russian. Each pack carries a unique code for the national digital marking system, and supply chain participants report movements into it.
Pricing and procurement
Products on the Vital and Essential Drugs List need a registered maximum manufacturer price. Public procurement follows federal procurement law and gives preference to medicines made in the EAEU.
Unregistered imports
Unregistered medicines can be imported only with a Minzdrav permit, for example for named patients.
Common challenges and practical solutions
| Challenge | Practical solution |
|---|---|
| GMP inspection timing | Ask early whether the site holds a valid EAEU or Russian GMP certificate and plan around renewal dates |
| Dossier gaps under EAEU rules | Run a gap analysis against EAEU requirements before commercial terms are final |
| Russian translation errors | Use one approved Russian text across dossier, labels and leaflet |
| Digital marking problems | Confirm the packaging site can print and verify marking codes before the first batch |
| Payment and banking delays | Agree the payment route and compliance checks before production starts |
| Long or changing routes | Build buffer stock and allow extra lead time in supply plans |
| Local preference in tenders | Consider technology transfer or dossier licensing to an EAEU site |
For dossier and registration support, see our dossier and registration service.
Conclusion
Sourcing for Russia depends on getting three things right: EAEU registration, a valid GMP certificate for each site, and compliant Russian packaging with digital marking. Add a clear compliance check on sanctions and export controls in every party's jurisdiction, and plan logistics with extra lead time.
PharmaTradz helps buyers compare GMP-certified manufacturers and CDMOs across several regions so that each product can come from a source that fits its regulatory and supply needs.
Frequently Asked Questions
Do medicines in Russia need EAEU registration?
Yes. Since 1 January 2026, medicines need registration under EAEU rules, with Minzdrav as the Russian authority.
Who inspects foreign manufacturing sites for Russia?
GMP inspections for an EAEU or Russian GMP certificate are organised by Minpromtorg.
What does Roszdravnadzor do?
It oversees medicines on the Russian market, including quality control and pharmacovigilance.
Is Russian-language labelling required?
Yes. Labels and leaflets must be in Russian, and each pack needs a digital marking code.
What stability zone applies to Russia?
Russia falls in climatic Zone II, so long-term stability data is typically generated at those conditions.
Do sanctions affect pharmaceutical trade with Russia?
Rules vary by jurisdiction, so buyers and suppliers must check current sanctions and export-control rules in their own countries before any deal.
Source Pharma Products & CDMO Services — other markets
Planning to register or source in Russian Federation?
Tell us the molecule, dosage form and target market. We will come back on the regulatory pathway and whether the project is realistic before you commit anything.
Submit a Requirement Ask a questionIf you already hold WHO-GMP, EU-GMP, USFDA or PIC/S approval, you are closer to supplying Russian Federation than you probably think.
Russian Federation's regulator publishes a register of authorised products. Look up any supplier's claims yourself — including ours.
